Moderna Doubles Size of Covid-19 Vaccine Supply Agreement With Japan
July 20 2021 - 7:26AM
Dow Jones News
By Robb M. Stewart
Moderna Inc. will sell an additional 50 million doses of its
Covid-19 vaccine and its updated variant booster candidate, if
authorized, to Japan's government and Takeda Pharmaceutical Co.,
doubling the size of its prior supply agreement.
Moderna said it is responsible for the manufacture and supply of
its vaccine candidate. Takeda, with the support of the Ministry of
Health, Labour and Welfare of Japan and Moderna, is responsible for
all import, local regulatory, development and distribution
activities in Japan for the additional 50 million doses beginning
in 2022, Moderna said.
Write to Robb M. Stewart at robb.stewart@wsj.com
(END) Dow Jones Newswires
July 20, 2021 07:16 ET (11:16 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
Moderna (NASDAQ:MRNA)
Historical Stock Chart
From Mar 2024 to Apr 2024
Moderna (NASDAQ:MRNA)
Historical Stock Chart
From Apr 2023 to Apr 2024
